AALL news

Latest 1 stories · newest Nov 17, 2026

AALL
Company files certificate for new Series B preferred stock

Allarity Therapeutics filed a certificate of designation for Series B preferred stock, which was authorized by the Board of Directors on November 12, 2026. No shares of the Series B have been issued as of the filing.

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same AALL feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/AALL/newsSTART FREE